Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (1131-1140 of 1,157) with videos related to

Pageof 116
Sort By:
Sleep|July 29, 2008
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study, Mauro Manconi, Luigi Ferini-Strambi, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
Annals of Neurology|May 23, 2024
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple SclerosisRosa Cortese, Marco Battaglini, Ferran Prados, et al.
European Journal of Neurology|September 23, 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trialEttore Beghi, Elisabetta Pupillo, Elisa Bianchi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
The New England Journal of Medicine|April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic LeukodystrophyFrancesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Neuroimage|October 10, 2018
Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networksCharley Gros, Benjamin De Leener, Atef Badji, et al.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2023
Sars-CoV2 infection in pregnant women with multiple sclerosisMaria Grazia Aprea, Irene Schiavetti, Emilio Portaccio, et al.
Pageof 116

Showing results (1131-1140 of 1,157) with videos related to

Sort By:
Pageof 116
Sleep|July 29, 2008
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study, Mauro Manconi, Luigi Ferini-Strambi, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
Annals of Neurology|May 23, 2024
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple SclerosisRosa Cortese, Marco Battaglini, Ferran Prados, et al.
European Journal of Neurology|September 23, 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trialEttore Beghi, Elisabetta Pupillo, Elisa Bianchi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
The New England Journal of Medicine|April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic LeukodystrophyFrancesca Fumagalli, Valeria Calbi, Vera Gallo, et al.
Neuroimage|October 10, 2018
Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networksCharley Gros, Benjamin De Leener, Atef Badji, et al.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2023
Sars-CoV2 infection in pregnant women with multiple sclerosisMaria Grazia Aprea, Irene Schiavetti, Emilio Portaccio, et al.
Pageof 116